摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis,trans-2,5-dimethylcyclopentanol | 65378-78-1

中文名称
——
中文别名
——
英文名称
cis,trans-2,5-dimethylcyclopentanol
英文别名
(2R,5R)-2,5-dimethylcyclopentan-1-ol
cis,trans-2,5-dimethylcyclopentanol化学式
CAS
65378-78-1
化学式
C7H14O
mdl
——
分子量
114.188
InChiKey
DJGMEPWATAGUNV-PHDIDXHHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    2,5-二甲基-环戊酮 在 lithium aluminium tetrahydride 作用下, 生成 cis,trans-2,5-dimethylcyclopentanol
    参考文献:
    名称:
    Reactions of methyl-substituted cyclopentanones with lithium aluminum hydride and methyllithium. Structural determinations and proton nuclear magnetic resonance study of the reaction products
    摘要:
    DOI:
    10.1021/jo00405a020
点击查看最新优质反应信息

文献信息

  • Orally active renin inhibitors
    申请人:PFIZER INC.
    公开号:EP0438233A2
    公开(公告)日:1991-07-24
    This invention relates to compounds of the formula wherein Q, Z, D, E, R3, R4, R5 and R6 are defined as below, and the pharmaceutically acceptable salts thereof are disclosed. The compounds are useful as antihypertensive agents.
    本发明涉及如下式的化合物 其中 Q、Z、D、E、R3、R4、R5 和 R6 的定义如下,本发明公开了其药学上可接受的盐类。这些化合物可用作降压药。
  • SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS
    申请人:ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    公开号:US20170015625A1
    公开(公告)日:2017-01-19
    A genus of arylsulfonamide derivatives of aminocycloalkanols is disclosed. The compounds are of the following genus: The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.
  • US5442044A
    申请人:——
    公开号:US5442044A
    公开(公告)日:1995-08-15
  • US9937186B2
    申请人:——
    公开号:US9937186B2
    公开(公告)日:2018-04-10
查看更多